KEMSA dispatches ARVs for over one million Kenyans

The Kenya Medical Supplies Authority (KEMSA) has sent out a shipment of antiretroviral drugs (ARVs) to support more than one million Kenyans, addressing concerns about HIV treatment following funding cuts.

Questions had been raised about Kenya’s ability to maintain HIV treatment programs after the United States halted funding for some global health programs under the U.S. Agency for International Development (USAID).

However, Health Cabinet Secretary Deborah Barasa on Friday reassured the public that the country has enough ARVs and testing kits to last between several months and two years.

“We are pleased to report that we have secure stock levels of key ARVs and testing kits, with supplies ranging from several months to close to two years,” she said.

Barasa stated that Kenya has an adequate supply of TLD, pediatric ARVs, Nevirapine suspension, and HIV testing materials. Additionally, the country has maintained access to Early Infant Diagnosis and Viral Load testing reagents.

“I am confident that our country can sustainably manage the HIV response through local innovations and strong leadership,” Barasa said.

In addition to ARVs, the shipment also includes medication for tuberculosis (TB) and malaria, which will be distributed through a partnership with the Mission for Essential Drugs and Supplies (MEDS) to ensure they reach patients efficiently.

The Health Ministry is prioritizing local pharmaceutical manufacturing to lessen reliance on foreign aid. It also integrates HIV patients into the national health insurance scheme and implements digital systems to enhance supply chain management.

Barasa stressed the importance of community engagement in addressing HIV, stating that empowering local groups would help reduce stigma and improve treatment access.

At the flag-off event, KEMSA Chief Executive Officer Dr. Waqo Ejersa highlighted that the partnership with MEDS will ensure a smooth and effective distribution of essential medicines across the country.

“The impact of today’s flag-off extends beyond immediate disease control—it is a step towards data-driven healthcare delivery in Kenya,” Ejersa said.

He also thanked the U.S. government, through the President’s Emergency Plan for AIDS Relief (PEPFAR), for its continued support of Kenya’s healthcare system.

Ejersa reaffirmed KEMSA’s commitment to ensuring transparency and efficiency in distributing vital medical supplies.